<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Am Coll Emerg Physicians Open</journal-id><journal-id journal-id-type="iso-abbrev">J Am Coll Emerg Physicians Open</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2688-1152</journal-id><journal-id journal-id-type="publisher-id">EMP2</journal-id><journal-title-group><journal-title>Journal of the American College of Emergency Physicians Open</journal-title></journal-title-group><issn pub-type="epub">2688-1152</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7228264</article-id><article-id pub-id-type="doi">10.1002/emp2.12034</article-id><article-id pub-id-type="publisher-id">EMP212034</article-id><article-categories><subj-group subj-group-type="overline"><subject>Review Article</subject></subj-group><subj-group subj-group-type="heading"><subject>REVIEW ARTICLES</subject><subj-group subj-group-type="heading"><subject>Infectious Disease</subject></subj-group></subj-group></article-categories><title-group><article-title>Novel coronavirus 2019 (COVID&#x02010;19): Emergence and implications for emergency care</article-title><alt-title alt-title-type="left-running-head">Yee et&#x000a0;al.</alt-title></title-group><contrib-group><contrib id="emp212034-cr-0001" contrib-type="author"><name><surname>Yee</surname><given-names>Jane</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="emp212034-aff-0001">
<sup>1</sup>
</xref><xref ref-type="bio" rid="d37e51">*</xref></contrib><contrib id="emp212034-cr-0002" contrib-type="author"><name><surname>Unger</surname><given-names>Lucy</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="emp212034-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="emp212034-cr-0003" contrib-type="author"><name><surname>Zadravecz</surname><given-names>Frank</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="emp212034-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="emp212034-cr-0004" contrib-type="author"><name><surname>Cariello</surname><given-names>Paloma</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="emp212034-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="emp212034-cr-0005" contrib-type="author"><name><surname>Seibert</surname><given-names>Allan</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="emp212034-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="emp212034-cr-0006" contrib-type="author"><name><surname>Johnson</surname><given-names>Michael Austin</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="emp212034-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="emp212034-cr-0007" contrib-type="author" corresp="yes"><name><surname>Fuller</surname><given-names>Matthew Joseph</given-names></name><degrees>MD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2880-5463</contrib-id><xref ref-type="aff" rid="emp212034-aff-0001">
<sup>1</sup>
</xref><address><email>matthew.fuller@hsc.utah.edu</email></address></contrib></contrib-group><aff id="emp212034-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Division of Emergency Medicine</named-content>
<institution>University of Utah School of Medicine</institution>
<city>Salt Lake City</city>
<named-content content-type="country-part">Utah</named-content>
<country country="US">USA</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>Matthew Joseph Fuller, MD, Division of Emergency Medicine, University of Utah School of Medicine, 30 N 1900 E, Salt Lake City, UT 84132, USA.<break/>Email: <email>matthew.fuller@hsc.utah.edu</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>22</day><month>2</month><year>2020</year></pub-date><elocation-id>10.1002/emp2.12034</elocation-id><history><date date-type="received"><day>01</day><month>2</month><year>2020</year></date><date date-type="rev-recd"><day>11</day><month>2</month><year>2020</year></date><date date-type="accepted"><day>11</day><month>2</month><year>2020</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2020 American College of Emergency Physicians <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2020 The Authors. <italic>JACEP Open</italic> published by Wiley Periodicals, Inc. on behalf of the American College of Emergency Physicians.</copyright-statement><license license-type="creativeCommonsBy-nc-nd"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non&#x02010;commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:EMP2-9999-na.pdf"/><abstract><title>Abstract</title><p>A novel coronavirus (COVID&#x02010;19) causing acute illness with severe symptoms has been isolated in Wuhan, Hubei Province, China. Since its emergence, cases have been found worldwide, reminiscent of severe acute respiratory syndrome and Middle East respiratory syndrome outbreaks over the past 2 decades. Current understanding of this epidemic remains limited due to its rapid development and available data. While occurrence outside mainland China remains low, the likelihood of increasing cases globally continues to rise. Given this potential, it is imperative that emergency clinicians understand the preliminary data behind the dynamics of this disease, recognize possible presentations of patients, and understand proposed treatment modalities.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="emp212034-kwd-0001">global health</kwd><kwd id="emp212034-kwd-0002">infectious disease</kwd><kwd id="emp212034-kwd-0003">public health</kwd></kwd-group><counts><fig-count count="3"/><table-count count="1"/><page-count count="7"/><word-count count="4033"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>edited-state</meta-name><meta-value>corrected-proof</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.0 mode:remove_FC converted:15.04.2020</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="self-citation" id="emp212034-cit-0047">
<string-name>
<surname>Yee</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Unger</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zadravecz</surname>
<given-names>F</given-names>
</string-name>, et&#x000a0;al. <article-title>Novel coronavirus 2019 (COVID&#x02010;19): Emergence and implications for emergency care</article-title>. <source xml:lang="en">Ann. Emerg. Med</source>. <year>2020</year>;<fpage>1</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1002/emp2.12034</pub-id>
<pub-id pub-id-type="pmid">31515181</pub-id></mixed-citation>
</p><fn-group><fn id="emp212034-note-0001"><p>Supervising Editor: Henry E. Wang, MD, MS.</p></fn><fn id="emp212034-note-0002"><p>
<bold>Funding and support</bold>: By JACEP Open policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see <ext-link ext-link-type="uri" xlink:href="http://www.icmje.org">http://www.icmje.org</ext-link>). The authors have stated that no such relationships exist.</p></fn></fn-group></notes></front><body><sec id="emp212034-sec-0010"><label>1</label><title>INTRODUCTION</title><p>Human coronavirus infections have once again been brought to global attention following the December 2019 emergence of a novel coronavirus (COVID&#x02010;19) isolated from pneumonia cases clustered at a market in Wuhan, China. These ribonucleic acid (RNA) viruses&#x02019; animal reservoirs, zoonotic transmission, high mutation rates, and demonstrated human&#x02010;to&#x02010;human spread has made them of particular public health concern. The current potential for global dissemination of the COVID&#x02010;19, given the co&#x02010;occurrence of Lunar New Year celebrations, in addition to the growing number of reported cases, adds urgency to understanding this outbreak. The confirmation of cases in 29 countries as of February 8, 2020 (Figure&#x000a0;<xref rid="emp212034-fig-0001" ref-type="fig">1</xref>) underscore the potential for COVID&#x02010;19 to rapidly evolve into a global pandemic. We provide a summary of the origins, epidemiology, and emergency department clinical management of COVID&#x02010;19.</p><fig fig-type="FIGURE" xml:lang="en" id="emp212034-fig-0001" orientation="portrait" position="float"><label>FIGURE 1</label><caption><p>Current countries with known cases of COVID&#x02010;19 as of February 7, 2020. Source: <ext-link ext-link-type="uri" xlink:href="http://www.CDC.gov">http://www.CDC.gov</ext-link>, accessed February 9, 2020</p></caption><graphic id="nlm-graphic-3" xlink:href="EMP2-9999-na-g002"/></fig></sec><sec id="emp212034-sec-0020"><label>2</label><title>WHAT IS A CORONAVIRUS?</title><sec id="emp212034-sec-0030"><label>2.1</label><title>Background on human coronaviruses</title><p>Based on genome sequencing, all known human coronaviruses have emerged from animal reservoirs.<xref rid="emp212034-bib-0001" ref-type="ref">
<sup>1</sup>
</xref> These RNA viruses have high mutation rates that allow them to adapt to varied hosts, increasing their potential for rapid human&#x02010;to&#x02010;human spread once a spillover event has occurred.<xref rid="emp212034-bib-0001" ref-type="ref">
<sup>1</sup>
</xref> The COVID&#x02010;19 is the seventh identified human coronavirus, and appears to have notable similarities to 2 other highly pathogenic human respiratory coronaviruses, severe acute respiratory syndrome coronavirus (SARS&#x02010;CoV) and Middle East respiratory syndrome coronavirus (MERS&#x02010;CoV),<xref rid="emp212034-bib-0002" ref-type="ref">
<sup>2</sup>
</xref> both of which have generated large&#x02010;scale public health responses in the last 2 decades.<xref rid="emp212034-bib-0003" ref-type="ref">
<sup>3</sup>
</xref>
</p><p>The COVID&#x02010;19, SARS&#x02010;CoV and MERS&#x02010;CoV belong to the family of betacoronoviruses, and likely share a common reservoir in bats.<xref rid="emp212034-bib-0004" ref-type="ref">
<sup>4</sup>
</xref> Intermediate hosts for zoonotic transmission to humans proposed for each of these 3 pathogenic strains include civets (SARS&#x02010;CoV), dromedary camels (MERS&#x02010;CoV),<xref rid="emp212034-bib-0001" ref-type="ref">
<sup>1</sup>
</xref> and an unconfirmed but likely mammalian source (COVID&#x02010;19).<xref rid="emp212034-bib-0005" ref-type="ref">
<sup>5</sup>
</xref> These betacoronaviruses typically produce respiratory and gastroenteritis symptoms in human and animal hosts, respectively. The remaining identified human coronaviruses (HCoV&#x02010;229E, HKU1, NL63, OC43) are limited in their severity of disease and often fail to produce symptoms greater than the common cold in immunocompetent hosts.<xref rid="emp212034-bib-0006" ref-type="ref">
<sup>6</sup>
</xref>
</p></sec><sec id="emp212034-sec-0040"><label>2.2</label><title>Recent coronavirus epidemics: SARS&#x02010;CoV and MERS&#x02010;CoV</title><p>Comparisons of the current COVID&#x02010;19 outbreak are being made to 2 recently emerged coronaviruses from zoonotic spillover events; SARS&#x02010;CoV (2002&#x02013;2004, originating from Guangdong Province, China) and the multiple MERS&#x02010;CoV outbreaks over the period (2012&#x02013;2016, originating from Saudi Arabia). Further, all 3 pathogenic coronavirus syndromes seem to present with similar symptoms of cough, fever, and pneumonia. The current COVID&#x02010;19 outbreak has eclipsed both the 2002 SARS outbreak and the 2012&#x02013;2016 MERS outbreak in number of cases and is closing in on a similar death toll; however, both SARS and MERS appear to have had higher case&#x02010;fatality rates (Table&#x000a0;<xref rid="emp212034-tbl-0001" ref-type="table">1</xref>) and worse severity of illness.<xref rid="emp212034-bib-0007" ref-type="ref">
<sup>7</sup>
</xref> In comparison to seasonal influenza globally, coronaviruses represent a smaller burden of disease, and fall well short of the 1918 Influenza pandemic (Table&#x000a0;<xref rid="emp212034-tbl-0001" ref-type="table">1</xref>).</p><table-wrap id="emp212034-tbl-0001" xml:lang="en" content-type="TABLE" orientation="portrait" position="float"><label>TABLE 1</label><caption><p>Comparison of COVID&#x02010;19 to SARS, MERS, 1918 pandemic influenza, and seasonal influenza</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">COVID&#x02010;19<xref ref-type="fn" rid="emp212034-tbl1-note-0001">a</xref>
<sup>,</sup>
<xref rid="emp212034-bib-0007" ref-type="ref">
<sup>7</sup>
</xref>, <xref rid="emp212034-bib-0008" ref-type="ref">
<sup>8</sup>
</xref>, <xref rid="emp212034-bib-0009" ref-type="ref">
<sup>9</sup>
</xref>, <xref rid="emp212034-bib-0038" ref-type="ref">
<sup>38</sup>
</xref>
</th><th align="left" rowspan="1" colspan="1">2002&#x02013;2004 SARS<xref rid="emp212034-bib-0039" ref-type="ref">
<sup>39</sup>
</xref>, <xref rid="emp212034-bib-0040" ref-type="ref">
<sup>40</sup>
</xref>
</th><th align="left" rowspan="1" colspan="1">2012&#x02013;2016 MERS<xref rid="emp212034-bib-0041" ref-type="ref">
<sup>41</sup>
</xref>, <xref rid="emp212034-bib-0042" ref-type="ref">
<sup>42</sup>
</xref>, <xref rid="emp212034-bib-0043" ref-type="ref">
<sup>43</sup>
</xref>
</th><th align="left" rowspan="1" colspan="1">1918 Pandemic influenza<xref rid="emp212034-bib-0016" ref-type="ref">
<sup>16</sup>
</xref>, <xref rid="emp212034-bib-0044" ref-type="ref">
<sup>44</sup>
</xref>
</th><th align="left" rowspan="1" colspan="1">Seasonal influenza (global)<xref rid="emp212034-bib-0044" ref-type="ref">
<sup>44</sup>
</xref>, <xref rid="emp212034-bib-0045" ref-type="ref">
<sup>45</sup>
</xref>, <xref rid="emp212034-bib-0046" ref-type="ref">
<sup>46</sup>
</xref>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">R<sub>0</sub>
<xref ref-type="fn" rid="emp212034-tbl1-note-0002">b</xref>
</td><td align="left" rowspan="1" colspan="1">2.2</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">1.9&#x02013;3.9</td><td align="left" rowspan="1" colspan="1">1.4&#x02013;2.8</td><td align="left" rowspan="1" colspan="1">0.9&#x02013;2.1</td></tr><tr><td align="left" rowspan="1" colspan="1">Total cases</td><td align="left" rowspan="1" colspan="1">37,525</td><td align="left" rowspan="1" colspan="1">8906</td><td align="left" rowspan="1" colspan="1">2494</td><td align="left" rowspan="1" colspan="1">500 million</td><td align="left" rowspan="1" colspan="1">7,780,000</td></tr><tr><td align="left" rowspan="1" colspan="1">Deaths</td><td align="left" rowspan="1" colspan="1">813</td><td align="left" rowspan="1" colspan="1">744</td><td align="left" rowspan="1" colspan="1">858</td><td align="left" rowspan="1" colspan="1">50 million</td><td align="left" rowspan="1" colspan="1">389,000</td></tr><tr><td align="left" rowspan="1" colspan="1">Case fatality rate (%)</td><td align="left" rowspan="1" colspan="1">3.1</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">34</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">0.05</td></tr></tbody></table><table-wrap-foot><fn id="emp212034-tbl1-note-0001"><label>a</label><p>COVID&#x02010;19 cases as of February 8, 2020.</p></fn><fn id="emp212034-tbl1-note-0002"><label>b</label><p>The number of new cases that can develop from 1 confirmed case.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder><license><license-p>This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</license-p></license></permissions></table-wrap></sec></sec><sec id="emp212034-sec-0050"><label>3</label><title>NOVEL CORONAVIRUS&#x02010;2019</title><sec id="emp212034-sec-0060"><label>3.1</label><title>Emergence of COVID&#x02010;19</title><p>On December 27, 2019, 3 adult patients presented with severe pneumonia to a hospital in Wuhan, China; a 49&#x02010;year&#x02010;old woman, a 61&#x02010;year&#x02010;old man, and a 32&#x02010;year&#x02010;old man. The woman was a known retailer in a seafood and wet animal wholesale market, while the older man was a frequent visitor. Similar circumstances and patients had been involved with the SARS&#x02010;CoV outbreak, leading to suspicions of an n&#x02010;CoV, and further testing revealed an n&#x02010;CoV as the likely etiologic agent in all 3 cases.<xref rid="emp212034-bib-0002" ref-type="ref">
<sup>2</sup>
</xref>
</p></sec><sec id="emp212034-sec-0070"><label>3.2</label><title>Transmission</title><p>Multiple reports have confirmed human&#x02010;to&#x02010;human transmission of the COVID&#x02010;19.<xref rid="emp212034-bib-0008" ref-type="ref">
<sup>8</sup>
</xref> When person&#x02010;to&#x02010;person spread has occurred with MERS&#x02010;CoV and SARS&#x02010;CoV, it is thought to have happened mainly via respiratory droplets produced when an infected person coughs or sneezes, similar to how Influenza and other respiratory pathogens spread. Inoculation via &#x0201c;fomite&#x02010;to&#x02010;face&#x0201d; contact is also likely a significant contributor to the spread of the virus.<xref rid="emp212034-bib-0008" ref-type="ref">
<sup>8</sup>
</xref>, <xref rid="emp212034-bib-0009" ref-type="ref">
<sup>9</sup>
</xref>, <xref rid="emp212034-bib-0010" ref-type="ref">
<sup>10</sup>
</xref> Recently, the first case of asymptomatic transmission was reported, though the theory remains unproven.<xref rid="emp212034-bib-0011" ref-type="ref">
<sup>11</sup>
</xref> This development raises concerns that the COVID&#x02010;19 may be similar to other viruses such as chickenpox and measles in that transmission may be possible during the incubation period or by patients with mild disease.</p></sec><sec id="emp212034-sec-0080"><label>3.3</label><title>Estimated morbidity and mortality</title><p>As of February 9, 2020, the mortality and morbidity rates of COVID&#x02010;19 remain in flux. Currently, a case fatality rate (CFR) of slightly &#x0003e;3% has been reported, with some reports as high as 5%.<xref rid="emp212034-bib-0009" ref-type="ref">
<sup>9</sup>
</xref>, <xref rid="emp212034-bib-0010" ref-type="ref">
<sup>10</sup>
</xref> For comparison, MERS and SARS exhibited CFRs of 35% and 15%, respectively.<xref rid="emp212034-bib-0009" ref-type="ref">
<sup>9</sup>
</xref> Mortality among COVID&#x02010;19 victims seems highest for the elderly and those with multiple comorbidities.</p></sec><sec id="emp212034-sec-0090"><label>3.4</label><title>Predictive epidemiologic modeling</title><p>Current epidemiologic models suggest transmission patterns similar to SARS and 1918 influenza pandemic. The World Health Organization (WHO) model, formulated by Ferguson and colleagues, suggests a basic reproductive number, R<sub>0</sub> (the number of new cases that can develop from 1 confirmed case) of 2.6&#x02013;3.1, 2&#x02010;fold higher than for seasonal Influenza.<xref rid="emp212034-bib-0012" ref-type="ref">
<sup>12</sup>
</xref> Multiple other published models report similar ranges.<xref rid="emp212034-bib-0012" ref-type="ref">
<sup>12</sup>
</xref>, <xref rid="emp212034-bib-0013" ref-type="ref">
<sup>13</sup>
</xref>, <xref rid="emp212034-bib-0014" ref-type="ref">
<sup>14</sup>
</xref> These models make assumptions regarding the latent and incubation periods based upon extrapolation from MERS&#x02010;CoV and SARS&#x02010;CoV. These models and the virus's behavior, thus far suggest the capability for sustained human&#x02010;to&#x02010;human transmission. Current rates of transmission are likely underestimated and will continue to evolve as the virus continues its spread, reporting practices evolve, and more data accrue. Many patients with infection likely experience only mild symptoms, do not present for evaluation, and thus, have not been included in statistics to date.</p></sec></sec><sec id="emp212034-sec-0100"><label>4</label><title>CLINICAL COURSE AND MANAGEMENT</title><sec id="emp212034-sec-0110"><label>4.1</label><title>Presentation</title><p>Knowledge of the COVID&#x02010;19 presentation is limited by case reports of those presenting to the hospital and the unknown number of asymptomatic patients. To date, the average incubation period is estimated to be a median of 5 days with a range between 2 and 14 days.<xref rid="emp212034-bib-0008" ref-type="ref">
<sup>8</sup>
</xref>, <xref rid="emp212034-bib-0015" ref-type="ref">
<sup>15</sup>
</xref> Based on an early descriptive study of patients admitted to a Wuhan regional referral hospital with confirmed COVID&#x02010;19 pneumonia, the majority had fever (83%&#x02013;98%) or cough (76%&#x02013;82%) and roughly one&#x02010;third had shortness of breath. Less common symptoms included myalgias (11%), rhinorrhea (10%), headache (8%), chest pain (2%), and gastrointestinal symptoms (3%).<xref rid="emp212034-bib-0002" ref-type="ref">
<sup>2</sup>
</xref> The vast majority of patients presented with &#x0003e;1 symptom. Patients were mostly men with a median age of 59 years.<xref rid="emp212034-bib-0002" ref-type="ref">
<sup>2</sup>
</xref>, <xref rid="emp212034-bib-0010" ref-type="ref">
<sup>10</sup>
</xref>, <xref rid="emp212034-bib-0016" ref-type="ref">
<sup>16</sup>
</xref>
</p><p>To date, over 29 countries have had confirmed cases of COVID&#x02010;19, although most cases have been in mainland China, with reported cases in all provinces.<xref rid="emp212034-bib-0018" ref-type="ref">
<sup>18</sup>
</xref> Outside of China, the patients with COVID&#x02010;19 infection have a median age of 45 years (range of 2&#x02013;74 years) and are most male (71%). Approximately one third of patients had complications such as acute respiratory distress syndrome, acute renal injury, septic shock, ventilator&#x02010;associated pneumonia, but it is unclear whether these cases were initial presentations or later stage disease.<xref rid="emp212034-bib-0002" ref-type="ref">
<sup>2</sup>
</xref> Approximately 23%&#x02013;32% of patients were admitted to the ICU, primarily for increased oxygen support. The majority of patients were sustained on nasal cannula, a smaller subset required high flow or non&#x02010;invasive ventilation, and an even smaller group requiring mechanical ventilation (4%&#x02013;10%) or extracorporeal membrane oxygenation (&#x0003c;5%).<xref rid="emp212034-bib-0002" ref-type="ref">
<sup>2</sup>
</xref>, <xref rid="emp212034-bib-0010" ref-type="ref">
<sup>10</sup>
</xref>, <xref rid="emp212034-bib-0015" ref-type="ref">
<sup>15</sup>
</xref> These data, however, do not include the global burden of COVID&#x02010;19. Approximately 80% of COVID&#x02010;19 deaths were in patients over 60 years old.<xref rid="emp212034-bib-0002" ref-type="ref">
<sup>2</sup>
</xref>, <xref rid="emp212034-bib-0008" ref-type="ref">
<sup>8</sup>
</xref> Over 75% of COVID&#x02010;19 deaths had comorbid medical conditions such as hypertension, diabetes, or cardiovascular disease.<xref rid="emp212034-bib-0017" ref-type="ref">
<sup>17</sup>
</xref> The vast majority of attributable deaths have occurred in China, although the Philippines and Hong Kong have also suffered 1 death each.<xref rid="emp212034-bib-0019" ref-type="ref">
<sup>19</sup>
</xref>
</p></sec><sec id="emp212034-sec-0120"><label>4.2</label><title>Diagnosis</title><p>Because the signs and symptoms of COVID&#x02010;19 are similar to other viral respiratory syndromes, health care professionals must obtain a detailed travel history in any patient presenting to the emergency department with fever and respiratory symptoms (Figure&#x000a0;<xref rid="emp212034-fig-0002" ref-type="fig">2</xref>). Any patient with flu&#x02010;like symptoms and travel to China or close contact with a person with confirmed COVID&#x02010;19 in the past 14 days should be considered a patient under investigation (PUI).<xref rid="emp212034-bib-0020" ref-type="ref">
<sup>20</sup>
</xref> A close contact is anyone within 6 feet of a confirmed COVID&#x02010;19 case for a prolonged period of time. Anyone with direct contact from secretions of a confirmed COVID&#x02010;19 patient is also a close contact.</p><fig fig-type="FIGURE" xml:lang="en" id="emp212034-fig-0002" orientation="portrait" position="float"><label>FIGURE 2</label><caption><p>US CDC recommended flowchart to identify and assess potential COVID&#x02010;19. Source: <ext-link ext-link-type="uri" xlink:href="http://www.CDC.gov">http://www.CDC.gov</ext-link>, accessed February 9, 2020</p></caption><graphic id="nlm-graphic-5" xlink:href="EMP2-9999-na-g003"/></fig><p>People who have traveled from Hubei and household members living with confirmed COVID&#x02010;19 not adhering to home care or isolation precautions are considered high risk exposures. Medium risk exposures include those traveling in China but outside of Hubei province without high risk exposures and household members using consistently proper home care and isolation precautions. Low risk exposures include being in the same indoor environment such as a waiting room for a prolonged period with a confirmed COVID&#x02010;19 case but not meeting the definition of close contact. No risk is identifiable for those who are in brief passing of a patient with confirmed COVID&#x02010;19.</p><p>Diagnosis of COVID&#x02010;19 is performed via molecular assays of respiratory specimens at WHO&#x02010;designated regional referral laboratories.<xref rid="emp212034-bib-0018" ref-type="ref">
<sup>18</sup>
</xref> On February 7, the CDC began the distribution of test kits for regional testing. More widely available testing is anticipated to be available soon. For institutions where testing is unavailable, testing by the CDC remains the only option. Confirmation of another viral respiratory illness in a PUI should not delay COVID&#x02010;19 testing. The decision to remove a patient from PUI status should be made after full clinical evaluation and consultation with public health authorities.</p></sec><sec id="emp212034-sec-0130"><label>4.3</label><title>Prevention</title><p>Currently, the transmission dynamics of COVID&#x02010;19 are poorly understood. Infection prevention guidance or COVID&#x02010;19 is based upon guidance previously developed for MERS and SARS as well as interim guidelines provided by the WHO and CDC.<xref rid="emp212034-bib-0021" ref-type="ref">
<sup>21</sup>
</xref>, <xref rid="emp212034-bib-0022" ref-type="ref">
<sup>22</sup>
</xref>
</p><p>In health care settings, triage and out&#x02010;of&#x02010;hospital protocols should identify a PUI before or upon ED arrival to minimize exposure to other patients and providers. Measures should include screening questions (including travel history) and respiratory and hand hygiene. After identifying a PUI, both hospital infection control and the local health department should be contacted immediately to prevent further spread amongst patients and health care workers. Any PUI should be given a surgical mask and placed in a private room or negative pressure room if available.<xref rid="emp212034-bib-0021" ref-type="ref">
<sup>21</sup>
</xref>
</p><p>Like MERS and SARS, it is assumed the COVID&#x02010;19 can be spread by the airborne route. Surgical face masks may be helpful for larger fluid droplets associated with coughing and sneezing, but they are unlikely to help with small airborne contaminants.<xref rid="emp212034-bib-0023" ref-type="ref">
<sup>23</sup>
</xref> Where available, respirators with an adequate seal and air movement directed through filters should be more effective.<xref rid="emp212034-bib-0024" ref-type="ref">
<sup>24</sup>
</xref>, <xref rid="emp212034-bib-0025" ref-type="ref">
<sup>25</sup>
</xref>, <xref rid="emp212034-bib-0026" ref-type="ref">
<sup>26</sup>
</xref> The proper usage of respirators and other personal protective equipment (PPE) including donning, fit, and frequent changing combined with proper hand hygiene represent the most effective method of preventing transmission in health care settings.<xref rid="emp212034-bib-0023" ref-type="ref">
<sup>23</sup>
</xref>, <xref rid="emp212034-bib-0027" ref-type="ref">
<sup>27</sup>
</xref>, <xref rid="emp212034-bib-0028" ref-type="ref">
<sup>28</sup>
</xref>
</p><p>If a patient needs to be hospitalized and an airborne infection isolation room is not available, the patient should be transferred to a facility with appropriate capabilities. Isolation rooms and care processes should be configured to minimize the number of health care personnel exposed to the patient as well as the duration of contact. It is paramount that all health care professionals use standard, contact, droplet, and airborne precautions in addition to an eye shield. PPE is especially important during aerosol&#x02010;generating procedures (eg, intubation) when transmission is likely increased.<xref rid="emp212034-bib-0022" ref-type="ref">
<sup>22</sup>
</xref>, <xref rid="emp212034-bib-0029" ref-type="ref">
<sup>29</sup>
</xref> After a patient vacates the room, it is unknown how long COVID&#x02010;19 says airborne. Entrance to the vacated room requires respiratory protection for a period that is specific to the ventilation and clearance rates for the room.</p></sec><sec id="emp212034-sec-0140"><label>4.4</label><title>Disposition</title><p>Not all COVID&#x02010;19 exposed or afflicted patients will need hospital admission. However, the decision to discharge a PUI for home isolation should be made in consultation with the local public health authorities.<xref rid="emp212034-bib-0030" ref-type="ref">
<sup>30</sup>
</xref> Patients should be directed to use appropriate hand hygiene, wear a simple facemask when around others, and remain isolated to a single room in the house whenever possible.<xref rid="emp212034-bib-0030" ref-type="ref">
<sup>30</sup>
</xref> Patients should only leave the house for medical attention after calling in advance to inform the medical office of their COVID&#x02010;19 PUI status.<xref rid="emp212034-bib-0031" ref-type="ref">
<sup>31</sup>
</xref> Although patients with mild symptoms can be discharged, there are reports of clinical decline in the second week of illness with over 50% of patients having dyspnea around day 8.<xref rid="emp212034-bib-0031" ref-type="ref">
<sup>31</sup>
</xref> Therefore, discharge may be inappropriate for patients who are unable to adhere to recommendations, return precautions, self&#x02010;monitoring, or those with inadequate housing. Patients with evidence of severe illness (hypotension, tachycardia, hypoxia, or other signs of shock) or those with comorbidities (older age, immunocompromised, chronic conditions such as diabetes, cardiovascular, or chronic lung disease) will require admission to isolation units and/or the ICU.</p></sec><sec id="emp212034-sec-0150"><label>4.5</label><title>Standard/supportive care</title><p>The WHO has published comprehensive, evidence&#x02010;based guidelines for caring for patients with severe acute respiratory infections thought to be related to COVID&#x02010;19.<xref rid="emp212034-bib-0020" ref-type="ref">
<sup>20</sup>
</xref>, <xref rid="emp212034-bib-0032" ref-type="ref">
<sup>32</sup>
</xref> The mainstay of treatment for suspected COVID&#x02010;19 infections is supportive care. In patients suspected of COVID&#x02010;19 infection, viral testing should be initiated early for disease confirmation and symptomatic treatment initiated as needed. Intravenous fluids should be used judiciously in patients without overt signs of fluid depletion as they may worsen oxygenation with increasing disease severity. In patients presenting with severe respiratory symptoms with radiographic findings, broad spectrum antibiotics should be administered early, since it is often not possible to differentiate between bacterial pneumonia and COVID&#x02010;19 infections.<xref rid="emp212034-bib-0020" ref-type="ref">
<sup>20</sup>
</xref>, <xref rid="emp212034-bib-0032" ref-type="ref">
<sup>32</sup>
</xref> As with MERS and SARS, steroids should be avoided.</p></sec><sec id="emp212034-sec-0160"><label>4.6</label><title>Lessons learned from SARS/MERS and emerging treatments</title><p>Beyond supportive care, there are no proven alternative treatments for coronavirus infections, although several potential therapies have been suggested and tested in limited settings. Data from both the SARS and MERS epidemics have demonstrated worse long&#x02010;term outcomes with the use of corticosteroids, and the use of steroids should only be reserved for patients requiring treatment for other disease processes.<xref rid="emp212034-bib-0032" ref-type="ref">
<sup>32</sup>
</xref>, <xref rid="emp212034-bib-0033" ref-type="ref">
<sup>33</sup>
</xref>, <xref rid="emp212034-bib-0034" ref-type="ref">
<sup>34</sup>
</xref>
</p><p>While currently not supported by the CDC or WHO guidelines, retrospective studies of the use of the protease inhibitors lopinavir and ritonavir during the SARS outbreak demonstrated improved survival when compared to case&#x02010;matched patients receiving standard therapy.<xref rid="emp212034-bib-0035" ref-type="ref">
<sup>35</sup>
</xref>, <xref rid="emp212034-bib-0036" ref-type="ref">
<sup>36</sup>
</xref> Ribavirin, however, resulted in worse SARS outcomes when compared to case&#x02010;matched control patients.<xref rid="emp212034-bib-0037" ref-type="ref">
<sup>37</sup>
</xref> In contrast, based upon limited data, Ribavirin seems to be associated with improved MERS survival.<xref rid="emp212034-bib-0037" ref-type="ref">
<sup>37</sup>
</xref> Similar randomized trials evaluating lopinavir/ritonavir for MERS have been designed, but are not yet completed. Current reports confirm that the Chinese Health Ministry is treating COVID&#x02010;19 infected patients with lopinavir/ritonavir, but there are no data on the outcomes.</p></sec></sec><sec id="emp212034-sec-0170"><label>5</label><title>CONCLUSION</title><p>The WHO has declared COVID&#x02010;19 a Public Health Emergency of International Concern. Currently, other seasonal infections cause more global disease than COVID&#x02010;19. However, there are concerning elements to this emerging infectious agent, including a greater R<sub>0</sub>, initial greater estimated mortality, and no inherent immunity in global populations. Though data remains limited, it is imperative that emergency clinicians understand the dynamics of this emerging epidemic at both the individual&#x02010; and population&#x02010;based levels, learn how to recognize those patients at risk or suffering from COVID&#x02010;19, and prepare to treat these patients in their clinical practice.</p></sec></body><back><bio id="d37e51"><p>Dr. Jane Yee, MD, is a Global Health Fellow in the Division of Emergency Medicine at the University of Utah. She completed residency training at Albert Einstein Medical Center in Philadelphia.</p><graphic xlink:href="EMP2-9999-na-g001.gif" position="anchor" id="nlm-graphic-1" orientation="portrait"/></bio><ref-list id="emp212034-bibl-0001"><title>REFERENCES</title><ref id="emp212034-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="emp212034-cit-0001">
<string-name>
<surname>Cui</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Shi</surname>
<given-names>Z&#x02010;L</given-names>
</string-name>. <article-title>Origin and evolution of pathogenic coronaviruses</article-title>. <source xml:lang="en">Nat Rev Microbiol</source>. <year>2019</year>;<volume>17</volume>(<issue>3</issue>):<fpage>181</fpage>&#x02010;<lpage>192</lpage>.<pub-id pub-id-type="pmid">30531947</pub-id></mixed-citation></ref><ref id="emp212034-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="emp212034-cit-0002">
<string-name>
<surname>Zhu</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>W</given-names>
</string-name>, et&#x000a0;al. <article-title>A novel coronavirus from patients with pneumonia in China, 2019</article-title>. <source xml:lang="en">N Engl J Med</source>. <year>2020</year>. NEJMoa2001017.</mixed-citation></ref><ref id="emp212034-bib-0003"><label>3</label><mixed-citation publication-type="miscellaneous" id="emp212034-cit-0003">
<collab collab-type="authors">Wuhan Municipal Health Committee [Internet]</collab>
. [Published February 2, <year>2020</year>]. Available at <ext-link ext-link-type="uri" xlink:href="http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989">http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989</ext-link>. Accessed February 2020.</mixed-citation></ref><ref id="emp212034-bib-0004"><label>4</label><mixed-citation publication-type="miscellaneous" id="emp212034-cit-0004">
<collab collab-type="authors">2019 Novel Coronavirus (2019&#x02010;nCoV) Situation Summary</collab>
| CDC [Internet]. 2020 [Published February 2, <year>2020</year>]. Available at <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/summary.html">https://www.cdc.gov/coronavirus/2019-ncov/summary.html</ext-link>. Accessed February 9, 2020.</mixed-citation></ref><ref id="emp212034-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="emp212034-cit-0005">
<string-name>
<surname>Callaway</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Cyranoski</surname>
<given-names>D</given-names>
</string-name>. <article-title>Why snakes probably aren't spreading the new China virus</article-title>. <source xml:lang="en">Nature</source> [Internet]. <year>2020</year> [Published February 2, 2020]. Available at <ext-link ext-link-type="uri" xlink:href="https://www.nature.com/articles/d41586-020-00180-8">https://www.nature.com/articles/d41586-020-00180-8</ext-link>. Accessed February 9, 2020.</mixed-citation></ref><ref id="emp212034-bib-0006"><label>6</label><mixed-citation publication-type="miscellaneous" id="emp212034-cit-0006">Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses: Trends in Microbiology [Internet]. [Published February 2, <year>2020</year>]. Available at <ext-link ext-link-type="uri" xlink:href="https://www.cell.com/trends/microbiology/fulltext/S0966-842X(16)00071-8?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0966842&#x000d7;16000718%3Fshowall%3Dtrue">https://www.cell.com/trends/microbiology/fulltext/S0966-842X(16)00071-8?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0966842&#x000d7;16000718%3Fshowall%3Dtrue</ext-link>. Accessed February 9, 2020.</mixed-citation></ref><ref id="emp212034-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="emp212034-cit-0007">
<string-name>
<surname>Wang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Horby</surname>
<given-names>PW</given-names>
</string-name>, <string-name>
<surname>Hayden</surname>
<given-names>FG</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>GF</given-names>
</string-name>. <article-title>A novel coronavirus outbreak of global health concern</article-title>. <source xml:lang="en">The Lancet</source> [Internet]. <year>2020</year> [Published February 2, 2020];0(0):S0140&#x02010;6736(20)30185&#x02010;9. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30185-9/abstract">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30185-9/abstract</ext-link>. Accessed February 1, 2020.</mixed-citation></ref><ref id="emp212034-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="emp212034-cit-0008">
<string-name>
<surname>Li</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Guan</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>P</given-names>
</string-name>, et&#x000a0;al. <article-title>Early transmission dynamics in Wuhan, China, of novel coronavirus&#x02010;infected pneumonia</article-title>. <source xml:lang="en">N Engl J Med</source>. <year>2020</year>;NEJMoa2001316.</mixed-citation></ref><ref id="emp212034-bib-0009"><label>9</label><mixed-citation publication-type="miscellaneous" id="emp212034-cit-0009">
<collab collab-type="authors">ProMED&#x02010;mail [Internet]</collab>
. [cited February 2, <year>2020</year>]. Available at <ext-link ext-link-type="uri" xlink:href="https://promedmail.org/">https://promedmail.org/</ext-link>. Accessed February 1, 2020.</mixed-citation></ref><ref id="emp212034-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="emp212034-cit-0010">
<string-name>
<surname>Perlman</surname>
<given-names>S</given-names>
</string-name>. <article-title>Another decade, another coronavirus</article-title>. <source xml:lang="en">N Engl J Med</source>. <year>2020</year>;<volume>0</volume>(<issue>0</issue>). <pub-id pub-id-type="doi">10.1056/NEJM200126</pub-id>. Accessed February 1, 2020.</mixed-citation></ref><ref id="emp212034-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="emp212034-cit-0011">
<string-name>
<surname>Rothe</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Schunk</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sothmann</surname>
<given-names>P</given-names>
</string-name>, et&#x000a0;al. <article-title>Transmission of 2019&#x02010;nCoV infection from an asymptomatic contact in Germany</article-title>. <source xml:lang="en">N Engl J Med</source>. <year>2020</year>; NEJMc2001468.</mixed-citation></ref><ref id="emp212034-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="emp212034-cit-0012">
<string-name>
<surname>Riou</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Althaus</surname>
<given-names>CL</given-names>
</string-name>. <article-title>Pattern of early human&#x02010;to&#x02010;human transmission of Wuhan 2019&#x02010;nCoV</article-title> [Internet]. <source xml:lang="en">Microbiology</source>. <year>2020</year> [cited February 2, 2020]. Available at <ext-link ext-link-type="uri" xlink:href="http://biorxiv.org/lookup/doi/10.1101/2020.01.23.917351">http://biorxiv.org/lookup/doi/10.1101/2020.01.23.917351</ext-link>
</mixed-citation></ref><ref id="emp212034-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="emp212034-cit-0013">
<string-name>
<surname>Imai</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Dorigatti</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Cori</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Donnelly</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Riley</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ferguson</surname>
<given-names>NM</given-names>
</string-name>. <article-title>Report 2: estimating the potential total number of novel coronavirus cases in Wuhan City, China</article-title>. MRC Centre for Global Infectious Disease. Imperial College. <year>2020</year>;<volume>6</volume>.</mixed-citation></ref><ref id="emp212034-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="emp212034-cit-0014">
<string-name>
<surname>Read</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Bridgen</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Cummings</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Ho</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Jewell</surname>
<given-names>CP</given-names>
</string-name>. <article-title>Novel coronavirus 2019&#x02010;nCoV: early estimation of epidemiological parameters and epidemic predictions</article-title> [Internet]. <source xml:lang="en">Infectious Diseases (except HIV/AIDS)</source>. <year>2020</year> [cited February 2, 2020]. Available at <ext-link ext-link-type="uri" xlink:href="http://medrxiv.org/lookup/doi/10.1101/2020.01.23.20018549">http://medrxiv.org/lookup/doi/10.1101/2020.01.23.20018549</ext-link>
</mixed-citation></ref><ref id="emp212034-bib-0015"><label>15</label><mixed-citation publication-type="miscellaneous" id="emp212034-cit-0015">
<collab collab-type="authors">Coronavirus 2019&#x02010;nCoV [Internet]</collab>
. [Published February 8, <year>2020</year>]. Available at <ext-link ext-link-type="uri" xlink:href="https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6">https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6</ext-link>. Accessed February 1, 2020.</mixed-citation></ref><ref id="emp212034-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="emp212034-cit-0016">
<string-name>
<surname>Coburn</surname>
<given-names>BJ</given-names>
</string-name>, <string-name>
<surname>Wagner</surname>
<given-names>BG</given-names>
</string-name>, <string-name>
<surname>Blower</surname>
<given-names>S</given-names>
</string-name>. <article-title>Modeling influenza epidemics and pandemics: insights into the future of swine flu (H1N1)</article-title>. <source xml:lang="en">BMC Med</source>. <year>2009</year>;<volume>7</volume>:<fpage>30</fpage>.<pub-id pub-id-type="pmid">19545404</pub-id></mixed-citation></ref><ref id="emp212034-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="emp212034-cit-0017">
<string-name>
<surname>Chen</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Dong</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study</article-title>. <source xml:lang="en">The Lancet</source> [Internet]. <year>2020</year> [Published February 2, 2020];0(0). Available at <ext-link ext-link-type="uri" xlink:href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30211-7/abstract">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30211-7/abstract</ext-link>. Accessed February 4, 2020.</mixed-citation></ref><ref id="emp212034-bib-0018"><label>18</label><mixed-citation publication-type="miscellaneous" id="emp212034-cit-0018">Coronavirus Has Now Spread To All Regions Of Mainland China [Internet]. NPR.org. [Published February 2, <year>2020</year>]. Available at <ext-link ext-link-type="uri" xlink:href="https://www.npr.org/sections/goatsandsoda/2020/01/30/801142924/coronavirus-has-now-spread-to-all-regions-of-mainland-china">https://www.npr.org/sections/goatsandsoda/2020/01/30/801142924/coronavirus-has-now-spread-to-all-regions-of-mainland-china</ext-link>. Accessed February 7, 2020.</mixed-citation></ref><ref id="emp212034-bib-0019"><label>19</label><mixed-citation publication-type="miscellaneous" id="emp212034-cit-0019">
<collab collab-type="authors">Statement on the meeting of the International Health Regulations</collab>
<year>2005</year> Emergency Committee regarding the outbreak of novel coronavirus 2019 (n&#x02010;CoV) on 23 January 2020 [Internet]. [Published February 2, 2020]. Available at <ext-link ext-link-type="uri" xlink:href="https://www.who.int/news-room/detail/23-01-2020-statement-on-the-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)">https://www.who.int/news-room/detail/23-01-2020-statement-on-the-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)</ext-link>. Accessed February 2, 2020.</mixed-citation></ref><ref id="emp212034-bib-0020"><label>20</label><mixed-citation publication-type="miscellaneous" id="emp212034-cit-0020">Interim Clinical Guidance for Management of Patients with Confirmed 2019 Novel Coronavirus (2019&#x02010;nCoV) Infection [Internet]. <year>2020</year> [Published February 2, 2020]. Available at <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html">https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html</ext-link>. Acccessed February 4, 2020.</mixed-citation></ref><ref id="emp212034-bib-0021"><label>21</label><mixed-citation publication-type="miscellaneous" id="emp212034-cit-0021">Laboratory guidance [Internet]. [Published February 2, <year>2020</year>]. Available at <ext-link ext-link-type="uri" xlink:href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance">https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance</ext-link>. Accessed February 3, 2020.</mixed-citation></ref><ref id="emp212034-bib-0022"><label>22</label><mixed-citation publication-type="miscellaneous" id="emp212034-cit-0022">Infection Control: Novel Coronavirus 2019 (2019&#x02010;nCoV) | CDC [Internet]. 2020 [Published February 2, <year>2020</year>]. Available at <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control.html">https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control.html</ext-link>
</mixed-citation></ref><ref id="emp212034-bib-0023"><label>23</label><mixed-citation publication-type="miscellaneous" id="emp212034-cit-0023">OSHA Fact Sheet: Respiratory Infection Control: Respirators Versus Surgical Masks | Occupational Safety and Health Administration [Internet]. [cited February 2, <year>2020</year>]. Available at <ext-link ext-link-type="uri" xlink:href="https://www.osha.gov/Publications/respirators-vs-surgicalmasks-factsheet.html">https://www.osha.gov/Publications/respirators-vs-surgicalmasks-factsheet.html</ext-link>. Accessed February 2, 2020.</mixed-citation></ref><ref id="emp212034-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="emp212034-cit-0024">
<string-name>
<surname>Tran</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Cimon</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Severn</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review</article-title>. <source xml:lang="en">PLoS One</source> [Internet]. <year>2012</year>;<volume>7</volume>(<issue>4</issue>). [cited February 2, 2020]. Available at <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338532/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338532/</ext-link>
</mixed-citation></ref><ref id="emp212034-bib-0025"><label>25</label><mixed-citation publication-type="miscellaneous" id="emp212034-cit-0025">Transmission&#x02010;Based Precautions | Basics | Infection Control | CDC&#x0201d; [Internet]. <year>2019</year> [cited February 2, 2020]. Available at <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/infectioncontrol/basics/transmission-based-precautions.html">https://www.cdc.gov/infectioncontrol/basics/transmission-based-precautions.html</ext-link>. Accessed February 2, 2020.</mixed-citation></ref><ref id="emp212034-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="emp212034-cit-0026">
<string-name>
<surname>Smith</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>MacDougall</surname>
<given-names>CC</given-names>
</string-name>, <string-name>
<surname>Johnstone</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>Effectiveness of N95 respirators versus surgical masks in protecting health care workers from acute respiratory infection: a systematic review and meta&#x02010;analysis</article-title>. <source xml:lang="en">CMAJ</source>. <year>2016</year>;<volume>188</volume>(<issue>8</issue>):<fpage>567</fpage>&#x02010;<lpage>574</lpage>.<pub-id pub-id-type="pmid">26952529</pub-id></mixed-citation></ref><ref id="emp212034-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="emp212034-cit-0027">
<string-name>
<surname>Radonovich</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Simberkoff</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Bessesen</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>N95 respirators vs medical masks for preventing influenza among health care personnel: a randomized clinical trial</article-title>. <source xml:lang="en">JAMA</source>. <year>2019</year>;<volume>322</volume>(<issue>9</issue>):<fpage>824</fpage>&#x02010;<lpage>833</lpage>.<pub-id pub-id-type="pmid">31479137</pub-id></mixed-citation></ref><ref id="emp212034-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="emp212034-cit-0028">
<string-name>
<surname>Cowling</surname>
<given-names>BJ</given-names>
</string-name>, <string-name>
<surname>Chan</surname>
<given-names>K&#x02010;H</given-names>
</string-name>, <string-name>
<surname>Fang</surname>
<given-names>VJ</given-names>
</string-name>, et&#x000a0;al. <article-title>Facemasks and hand hygiene to prevent influenza transmission in households</article-title>. <source xml:lang="en">Ann Int Med</source>. <year>2009</year>;<volume>151</volume>(<issue>7</issue>):<fpage>437</fpage>&#x02010;<lpage>446</lpage>.<pub-id pub-id-type="pmid">19652172</pub-id></mixed-citation></ref><ref id="emp212034-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="emp212034-cit-0029">
<string-name>
<surname>Raboud</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Shigayeva</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>McGeer</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>Risk factors for SARS transmission from patients requiring intubation: a multicentre investigation in Toronto, Canada</article-title>. <source xml:lang="en">PLoS One</source> [Internet]. <year>2010</year>;<volume>5</volume>(<issue>5</issue>). [cited February 2, 2020]. Available at <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873403/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873403/</ext-link>
</mixed-citation></ref><ref id="emp212034-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="emp212034-cit-0030">
<string-name>
<surname>MacIntyre</surname>
<given-names>CR</given-names>
</string-name>, <string-name>
<surname>Chughtai</surname>
<given-names>AA</given-names>
</string-name>. <article-title>Facemasks for the prevention of infection in healthcare and community settings</article-title>. <source xml:lang="en">BMJ</source> [Internet]. <year>2015</year>:<fpage>350</fpage> [cited February 2, 2020]. Available at <ext-link ext-link-type="uri" xlink:href="https://www.bmj.com/content/350/bmj.h694">https://www.bmj.com/content/350/bmj.h694</ext-link>. Accessed February 2, 2020.</mixed-citation></ref><ref id="emp212034-bib-0031"><label>31</label><mixed-citation publication-type="miscellaneous" id="emp212034-cit-0031">Interim Guidance: Home Care for 2019&#x02010;nCoV | CDC [Internet]. 2020 [cited February 2, 2020]. Available at <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-home-care.html">https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-home-care.html</ext-link>. Accessed February 2, 2020.</mixed-citation></ref><ref id="emp212034-bib-0032"><label>32</label><mixed-citation publication-type="miscellaneous" id="emp212034-cit-0032">Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected [Internet]. [cited February 9, <year>2020</year>]. Available at <ext-link ext-link-type="uri" xlink:href="https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected">https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected</ext-link>. Accessed February 2, 2020.</mixed-citation></ref><ref id="emp212034-bib-0033"><label>33</label><mixed-citation publication-type="miscellaneous" id="emp212034-cit-0033">Interim Clinical Guidance for Management of Patients with Confirmed 2019 Novel Coronavirus (2019&#x02010;nCoV) Infection [Internet]. <year>2020</year> [cited February 8, 2020]. Available at <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html">https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html</ext-link>. Accessed February 2, 2020.</mixed-citation></ref><ref id="emp212034-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="emp212034-cit-0034">
<string-name>
<surname>Kargel</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Lapinsky</surname>
<given-names>SE</given-names>
</string-name>. <article-title>Pro/con clinical debate: steroids are a key component in the treatment of SARS. Con: no, steroids are not a key component of the treatment regimen for SARS</article-title>. <source xml:lang="en">Crit Care Lond Engl.</source>
<year>2004</year>;<volume>8</volume>(<issue>2</issue>):<fpage>105</fpage>&#x02010;<lpage>107</lpage>.</mixed-citation></ref><ref id="emp212034-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="emp212034-cit-0035">
<string-name>
<surname>Chan</surname>
<given-names>KS</given-names>
</string-name>, <string-name>
<surname>Lai</surname>
<given-names>ST</given-names>
</string-name>, <string-name>
<surname>Chu</surname>
<given-names>CM</given-names>
</string-name>, et&#x000a0;al. <article-title>Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study</article-title>. <source xml:lang="en">Hong Kong Med J Xianggang Yi Xue Za Zhi</source>. <year>2003</year>;<volume>9</volume>(<issue>6</issue>):<fpage>399</fpage>&#x02010;<lpage>406</lpage>.<pub-id pub-id-type="pmid">14660806</pub-id></mixed-citation></ref><ref id="emp212034-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="emp212034-cit-0036">
<string-name>
<surname>Chu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Cheng</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Hung</surname>
<given-names>I</given-names>
</string-name>, et&#x000a0;al. <article-title>Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings</article-title>. <source xml:lang="en">Thorax</source>. <year>2004</year>;<volume>59</volume>(<issue>3</issue>):<fpage>252</fpage>&#x02010;<lpage>256</lpage>.<pub-id pub-id-type="pmid">14985565</pub-id></mixed-citation></ref><ref id="emp212034-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="emp212034-cit-0037">
<string-name>
<surname>Dyall</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gross</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Kindrachuk</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>Middle east respiratory syndrome and severe acute respiratory syndrome: current therapeutic options and potential targets for novel therapies</article-title>. <source xml:lang="en">Drugs</source>. <year>2017</year>;<volume>77</volume>(<issue>18</issue>):<fpage>1935</fpage>&#x02010;<lpage>1966</lpage>.<pub-id pub-id-type="pmid">29143192</pub-id></mixed-citation></ref><ref id="emp212034-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="emp212034-cit-0038">
<string-name>
<surname>Riou</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Althaus</surname>
<given-names>CL.</given-names>
</string-name>
<article-title>Pattern of early human&#x02010;to&#x02010;human transmission of Wuhan 2019&#x02010;nCoV [Internet]</article-title>. <source xml:lang="en">Microbiology</source>. <year>2020</year> [cited February 8, 2020]. Available at <ext-link ext-link-type="uri" xlink:href="http://biorxiv.org/lookup/doi/10.1101/2020.01.23.917351">http://biorxiv.org/lookup/doi/10.1101/2020.01.23.917351</ext-link>. Accessed February 2, 2020.</mixed-citation></ref><ref id="emp212034-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="emp212034-cit-0039">
<string-name>
<surname>Bauch</surname>
<given-names>CT</given-names>
</string-name>, <string-name>
<surname>Lloyd&#x02010;Smith</surname>
<given-names>JO</given-names>
</string-name>, <string-name>
<surname>Coffee</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Galvani</surname>
<given-names>AP</given-names>
</string-name>. <article-title>Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future</article-title>. <source xml:lang="en">Epidemiology</source>. <year>2005</year>;<volume>16</volume>(<issue>6</issue>):<fpage>791</fpage>&#x02010;<lpage>801</lpage>.<pub-id pub-id-type="pmid">16222170</pub-id></mixed-citation></ref><ref id="emp212034-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="emp212034-cit-0040">
<string-name>
<surname>Leung</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Hedley</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Ho</surname>
<given-names>L&#x02010;M</given-names>
</string-name>, <string-name>
<surname>Chau</surname>
<given-names>P</given-names>
</string-name>. <article-title>The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients</article-title>. <source xml:lang="en">Ann Intern Med</source>. <year>2004</year>;<volume>141</volume>(<issue>9</issue>):<fpage>662</fpage>&#x02010;<lpage>673</lpage>.<pub-id pub-id-type="pmid">15520422</pub-id></mixed-citation></ref><ref id="emp212034-bib-0041"><label>41</label><mixed-citation publication-type="miscellaneous" id="emp212034-cit-0041">WHO | Middle East respiratory syndrome coronavirus (MERS&#x02010;CoV) [Internet]. WHO. [cited February 8, 2020]. Available at <ext-link ext-link-type="uri" xlink:href="http://www.who.int/emergencies/mers-cov/en/">http://www.who.int/emergencies/mers-cov/en/</ext-link>. Accessed February 2, 2020.</mixed-citation></ref><ref id="emp212034-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="emp212034-cit-0042">
<string-name>
<surname>Choi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Jung</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>BY</given-names>
</string-name>, <string-name>
<surname>Hur</surname>
<given-names>YJ</given-names>
</string-name>, <string-name>
<surname>Ki</surname>
<given-names>M</given-names>
</string-name>. <article-title>High reproduction number of Middle East respiratory syndrome coronavirus in nosocomial outbreaks: mathematical modelling in Saudi Arabia and South Korea</article-title>. <source xml:lang="en">J Hosp Infect</source>. <year>2018</year>;<volume>99</volume>(<issue>2</issue>):<fpage>162</fpage>&#x02010;<lpage>168</lpage>.<pub-id pub-id-type="pmid">28958834</pub-id></mixed-citation></ref><ref id="emp212034-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="emp212034-cit-0043">
<string-name>
<surname>Biggerstaff</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Cauchemez</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Reed</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Gambhir</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Finelli</surname>
<given-names>L</given-names>
</string-name>. <article-title>Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature</article-title>. <source xml:lang="en">BMC Infect Dis</source> [Internet]. <year>2014</year>:<fpage>14</fpage> [cited February 7, 2020]. Available at <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169819/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169819/</ext-link>. Accessed February 7, 2020.<pub-id pub-id-type="pmid">24405719</pub-id></mixed-citation></ref><ref id="emp212034-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="emp212034-cit-0044">
<string-name>
<surname>Johnson</surname>
<given-names>NPAS</given-names>
</string-name>, <string-name>
<surname>Mueller</surname>
<given-names>J.</given-names>
</string-name>
<article-title>Updating the accounts: global mortality of the 1918&#x02013;1920 &#x0201c;Spanish&#x0201d; influenza pandemic</article-title>. <source xml:lang="en">Bull Hist Med</source>. <year>2002</year>;<volume>76</volume>(<issue>1</issue>):<fpage>105</fpage>&#x02010;<lpage>115</lpage>.<pub-id pub-id-type="pmid">11875246</pub-id></mixed-citation></ref><ref id="emp212034-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="emp212034-cit-0045">
<string-name>
<surname>Chowell</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Miller</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Viboud</surname>
<given-names>C</given-names>
</string-name>. <article-title>Seasonal influenza in the United States, France, and Australia: transmission and prospects for control</article-title>. <source xml:lang="en">Epidemiol Infect</source>. <year>2008</year>;<volume>136</volume>(<issue>6</issue>):<fpage>852</fpage>&#x02010;<lpage>864</lpage>.<pub-id pub-id-type="pmid">17634159</pub-id></mixed-citation></ref><ref id="emp212034-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="emp212034-cit-0046">
<string-name>
<surname>Paget</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Spreeuwenberg</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Charu</surname>
<given-names>V</given-names>
</string-name>, et&#x000a0;al. <article-title>Global mortality associated with seasonal influenza epidemics: new burden estimates and predictors from the GLaMOR Project</article-title>. <source xml:lang="en">J Glob Health</source> [Internet]. <volume>9</volume>(<issue>2</issue>). [cited February 7, <year>2020</year>]. Available at <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815659/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815659/</ext-link>. Accessed February 7, 2020.</mixed-citation></ref></ref-list></back></article>